Radcliffe Capital Management, L.P. Ibere Pharmaceuticals Transaction History

Radcliffe Capital Management, L.P.

  • $4.34 Million
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$0.11 - $9.94 $2,986 - $269,871
27,150 Added 9.05%
327,150 $3.24 Million
Q2 2021

Aug 16, 2021
BUY
$9.65 - $9.95 $2.9 Million - $2.99 Million
300,000 New
300,000 $2.9 Million

Others Institutions Holding IBER

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About IBERE PHARMACEUTICALS

IBER Quotes by TradingView
  • Ticker IBER
  • Exchange NYSE
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 13,800,000
  • Description
  • Ibere Pharmaceuticals does not have significant operations. It focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses. The company was incorporated in 2020 and is based in Philadelphia, Pennsylvania.
More about IBER
Track This Portfolio

Track Radcliffe Capital Management, L.P. Portfolio

Follow Radcliffe Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radcliffe Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Radcliffe Capital Management, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email